San Diego, CA – Enlyte recently released the third portion of its Pharmacy Solutions Drug Trends Series Report, which analyzes the state of pharmacy trends in workers’ comp.
In part three of the series, Enlyte explores trends experienced in the opioid drug category, noting that opioids continue to represent a decreasing proportion of overall scripts and costs, with favorable trends seen in important markers such as morphine equivalent dose (MED), duration of use, and access to guideline-supported measures including medication-assisted treatment (MAT) and overdose rescue medication (naloxone).
Key highlights included:
- Opioid scripts dropped 1.3% and costs were down 2.5% from 2021. While opioids continue to decline as a percentage of total script volume and costs, it remains essential to promote evidence-based risk management strategies.
- The number of injured workers using opioids has continued to decline, decreasing by 2.7 percentage points in 2022.
- In 2022, the majority (17) of the top 20 states ranked by opioid script volume experienced decreases in high MED (scripts with an average daily MED of at least 90 milligrams).
- Opioid claims using MAT remained relatively flat through 2022, however, of those claims with MAT medications prescribed, MAT scripts increased 11.6%.
Read the free report: Enlyte Pharmacy Solutions Drug Trends Report Part 3
Enlyte is a WorkCompWire ad partner.
This is NOT a paid placement.